Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Master Agreement

If I recall correctly, both TPL and PTSC assigned their rights to the MMP to PDS (i.e., PDS is the owner of record).

FWIW - which may be some re-thinking....

SGE

Share
New Message
Please login to post a reply